Nov
DEC
Jan
21
2014
2015
2016
1 captures
21 Dec 15 - 21 Dec 15
Close
Help
Skip to main content
Access brought to you by:
LOCKSS
Login
Search for this keyword
Advanced Search
Main menu
HOME
BROWSE BY CONFERENCE
BROWSE BY DISCIPLINE
-- All Disciplines --
Anesthesiology
Cardiology & Cardiovascular Medicine
Dentistry
Dermatology
Endocrinology, Diabetes & Metabolism
Emergency Medicine & Critical Care
Hematology
Hepatology
Infectious Diseases
Nephrology
Neurology
Nutrition
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopaedics & Sports Medicine
Psychiatry & Psychology
Pulmonary & Respiratory Medicine
Radiology
Rheumatology
Veterinary Medicine
ABOUT
About Us
International Medical Advisory Board
Reprints
Librarian resources
Contact us
Help
Hypertensive Disease
The Lifetime Risk of Nephropathy and Its Progression May Be Greater than Previously Reported
Early Treatment with Olmesartan Delays Progression of Nephropathy in Patients with Type 2 Diabetes
New Perspectives on Current Hypertension Guidelines
The Risk of Exercise-Related Sudden Death in Hypertensive Patients
Optimal Blood Pressure in the Hypertensive Patient and the J-Curve Dilemma
An Innovative Approach to Cardiovascular Risk Reduction: Results from the C-CHAP Study
Olmesartan Reduces Microalbuminuria in Patients with Type 2 Diabetes
Combination Therapy in the Management of Hypertension
RAAS Inhibitors and the Prevention of Vascular Damage in Patients with Prehypertension
Candesartan and Amlodipine: Effect on the Incidence of Cardiovascular Events and New-Onset Diabetes
Pages
Previous
Next
1
…
6
7
8
9
10
11
12
13
14
